Prevention of Rh D alloimmunisation. Number 4, May 1999, Clinical management guidelines for obstetrician–gynaecologists. Int J Gynaecol Obstet 1999 Jul;66(1):63-70.
Ultrasound assessment of the fetal middle cerebral artery peal systolic velocity: a comparison of the near-field versus far-field vessel. Am J Obstet Gynecol 2003 Oct;189(4):986-989.
The effect of fetal behavioural states on middle cerebral artery peak systolic velocity. Am J Obstet Gynecol 2004 Oct;191(4): 1283-1287.
B et al, Am J OG 1988.
N England Journal of Medicine 2000; 342:9-14.
Noninvasive technique to detect fetal anaemia due to red blood cell alloimmunisation: a systematic review. Obstet Gynecol 2001 Sep;98(3):509-517.
Doppler ultrasound versus amniocentesis to predict fetal anaemia. N Engl J Med 2006 Jul;335:156-164.
Benefits and risks of fetal red cell transfusion after 32 weeks gestation. Eur J Obstet Gynecol Reproduct Biol 2000 Oct;92(1):91-96.
Complications of intrauterine intravascular transfusion for fetal anaemia due to maternal red-cell alloimmunisation. Am J Obstet Gynecol 2005 Jan;192(1):171-177.
Longitudinal measurement of peak systolic velocity in the fetal middle cerebral artery for monitoring pregnancies complicated by red cell alloimmunisation: a prospective multicentre trial with intention to treat. BJOG 2002 Jul;109(7):746-752.
Middle cerebral artery peak systolic velocity: is the standard of care for the diagnosis of fetal anaemia? J Ultrasound Med 2005 May;24(5):697-702.
Fetal transfusion for red blood cell alloimmunisation in pregnancy. Obstet Gynecol 1996 Jul;88(1): 137-150.
Peadiatric outcome in rhesus haemolytic disease treated with and without intrauterine transfusion. Am J Obstet Gynecol 2008 Jan;198(1):54.e1-54.e4.
